Immunalysis

What Immunalysis does

Immunalysis is a toxicology-focused diagnostics brand that has operated since 1976 and now functions as a product line within Abbott Toxicology, a division of Abbott Laboratories (NYSE: ABT, founded 1888). Headquartered in Pomona, California with 11–50 employees, the company supplies clinical laboratories and healthcare providers with a comprehensive portfolio for drugs-of-abuse screening. The core offering is the ImmTox™ 270 Benchtop Analyzer, an automated immunoassay system designed for oral fluid and urine screening applications, complemented by Quantisal™ oral fluid collection devices, a broad reagent menu covering commonly misused substances, rapid point-of-collection screening devices (iCup), and a comprehensive reagent menu for both oral fluid and urine drugs-of-abuse testing.

The business model combines one-time hardware placements (ImmTox 270 analyzer, iCup devices) with recurring consumables revenue from reagents and Quantisal collection kits, supplemented by professional services (technical consulting and lab startup support) and managed laboratory testing services that the company itself operates. Distribution relies on Abbott's global enterprise sales motion, direct customer engagement through a toll-free sales line and dedicated email, and product catalog distribution. Target buyers are clinical laboratories running compliance-driven drug-testing programs and healthcare providers addressing prescription drug misuse and illicit drug abuse; segmentation is horizontal across these use cases rather than vertically concentrated in any single end market.

As a wholly-owned brand within Abbott's toxicology division, Immunalysis combines specialized clinical toxicology IP and long-standing category trademarks (ImmTox, Quantisal) with Abbott's established global distribution, regulatory expertise, brand recognition, and integration with adjacent diagnostics segments. This parent-backed commercial reach materially extends what an 11–50 employee standalone entity of equivalent product footprint could achieve, and the company's own technical consulting services embed Abbott's regulatory expertise into customer onboarding for compliance-driven laboratory operations.

Name

Immunalysis

Legal name

Abbott Laboratories

Website

https://immunalysis.com

Company type

Public

Founded year

1888

Operating status

Operating

Headcount range

11–50 employees

Short description

Immunalysis is a toxicology brand within Abbott Toxicology that supplies clinical laboratories and healthcare providers with the ImmTox 270 Benchtop Analyzer, Quantisal oral fluid collection devices, reagents, and rapid screening devices for drugs-of-abuse testing, plus lab startup and testing services.

Ownership category

akta.pro rank

Product category

Clinical Toxicology Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151), Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Clinical Chemistry & Immunoassay Systems (HLAHAAAA), Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB)

Keywords

• Drugs of abuse testing
• Clinical toxicology reagents
• Oral fluid collection devices
• Benchtop screening analyzer
• Urine drug screening

Headquarters

HQ city

Pomona

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Supply Chain, Personnel, Marketing or Sales

Revenue model

1. Hardware Sales: Sale of ImmTox™ 270 Benchtop Analyzer systems and rapid screening devices for clinical toxicology testing.
2. Reagent Sales: Comprehensive reagent menu for oral fluid and urine drugs of abuse testing, providing ongoing consumables revenue.
3. Technical Consulting & Lab Startup Services: Expert consulting services for establishing and maintaining compliance-driven laboratories, including initial application processes, inspections, and lab management. Staff guidance through laboratory licensure and accreditation preparation.
4. Laboratory Testing Services: Urine laboratory drug testing and oral fluid drug testing laboratory services.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Immunalysis, operating as a product line within Abbott Toxicology, manufactures and sells clinical toxicology screening products including the ImmTox 270 Benchtop Analyzer, Quantisal oral fluid collection devices, rapid drug screening devices, and a comprehensive reagent menu for urine and oral fluid drugs of abuse testing. The offering also includes laboratory testing services and technical consulting for compliance-driven lab setup and accreditation.

Product overview

Abbott Toxicology offers a comprehensive portfolio of clinical toxicology solutions organized as a platform-plus-modules architecture. The core offerings include the ImmTox™ 270 Benchtop Analyzer for automated screening, Quantisal™ Oral Fluid Collection Devices for specimen collection, Rapid Drug Screening Devices (iCup) for point-of-collection testing, and Reagents for both oral fluid and urine drugs of abuse testing. These products are complemented by Technical Consulting & Lab Startup Services to help laboratories establish compliance-driven operations, and the Learning XChange training portal for on-demand education. The portfolio provides complete laboratory setup capabilities including systems, reagents, collection devices, and technical consulting services.

Differentiator

Problem solved

Functional benefit

Brands

• ImmTOX™ 270 Benchtop Analyzer: A user-friendly and efficient benchtop screening system for clinical toxicology, enhancing patient care quality.
• Quantisal™

Products and services

• ImmTox 270 Benchtop Analyzer

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Quest Diagnostics: Large reference lab with substantial workplace and clinical toxicology testing volumes; competes with Immunalysis's lab testing services arm and is also a downstream customer for IVD reagents/instruments.
• Thermo Fisher Scientific (Diagnostics / Immunoassay): Large diagnostics and immunoassay franchise offering clinical chemistry and toxicology reagents and instruments; competes with Immunalysis in the lab-based drugs-of-abuse testing workflow with broader portfolio scale.
• Roche Diagnostics: Global leader in clinical chemistry and immunoassay platforms (cobas) used for toxicology screening; overlapping customer base of clinical laboratories and similar reagents-plus-instrument business model.
• Siemens Healthineers: Operates Atellica/ADVIA Centaur immunoassay systems and comprehensive clinical chemistry/reagents menus used in routine and specialized toxicology testing at hospital labs.
• Beckman Coulter (Danaher): Major clinical chemistry and immunoassay instrument/reagent vendor whose analyzers are commonly used for drugs-of-abuse testing alongside or versus Immunalysis's benchtop analyzer.

Direct peers

• Bio-Rad Laboratories: Clinical diagnostics business focused on immunoassay reagents, including toxicology/DoA test menus on automated platforms; directly comparable to Immunalysis's reagent-centric drugs-of-abuse offering.
• OraSure Technologies: Specializes in oral fluid collection devices and rapid diagnostic tests, including drug abuse screening; Quantisal-style collection-device economics make it the most comparable peer to Immunalysis's Quantisal line.
• Psychemedics: Niche specialty toxicology lab offering drug testing services to clinical and workplace markets; comparable as a focused toxicology testing-services and collection-device specialist.
• Aegis Sciences Corporation: Specialty clinical toxicology laboratory providing urine and oral fluid drug testing with proprietary methodologies; directly comparable to Abbott Toxicology's lab testing services line that overlaps with Immunalysis.

Emerging players

• Premier Biotech: Smaller specialty diagnostics vendor of rapid drug screening devices (oral fluid and urine) and reagents, directly comparable in product mix to Immunalysis's rapid screening and reagent offerings but at smaller scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Immunalysis